May 14 2010
Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors.
"We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as a Board member," said Tom Wilder, who joined in February 2010 as President and Chief Executive Officer. "We will utilize these funds to continue our development programs, including the introduction of our initial WEB™ product line." The WEB™ aneurysm embolization system provides a new treatment alternative for cerebral aneurysms, especially those prone to a high rate of recurrence and re-treatment.
SOURCE Sequent Medical, Inc.